Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Applications of iPSC-derived beta cells from patients with diabetes

1 Apr 2021

Abstract excerpt

Improved stem cell-derived pancreatic islet (SC-islet) differentiation protocols robustly generate insulin-secreting β cells from patient induced pluripotent stem cells (iPSCs). These advances are enabling in vitro disease modeling studies and the development of an autologous diabetes cell replacement therapy. SC-islet technology elucidates key features of human pancreas development and diabetes disease...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diabetes Management and Research
Share to Pancreatic function and diabetes

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 33948571
DOI: 10.1016/j.xcrm.2021.100238

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Applications of iPSC-derived beta cells from patients with diabetesPMID 33948571Read ↗

Stem cell approaches for diabetes: towards beta cell replacementSemantic proximity Read ↗

Stem Cell-Derived β Cells: A Versatile Research Platform to Interrogate the Genetic Basis of β Cell Dysfunction.Semantic proximity Read ↗

Human Pluripotent Stem Cells to Model Islet Defects in Diabetes.Semantic proximity Read ↗

Stem cell-derived pancreatic beta cells: a step closer to functional diabetes treatment?Semantic proximity Read ↗

New tools for experimental diabetes research: Cellular reprogramming and genome editing.Semantic proximity Read ↗

Towards a Functional Cure for Diabetes Using Stem Cell-Derived Beta Cells: Are We There Yet?Semantic proximity Read ↗

Recent Progress of Research Regarding the Applications of Stem Cells for Treating Diabetes MellitusSemantic proximity Read ↗

iPSC technology‐based regenerative therapy for diabetesSemantic proximity Read ↗

The prospect of induced pluripotent stem cells for diabetes mellitus treatmentSemantic proximity Read ↗

Endocrine Pancreas Development and Dysfunction Through the Lens of Single-Cell RNA-SequencingSemantic proximity Read ↗

Genome editing of human pancreatic beta cell models: problems, possibilities and outlookSemantic proximity Read ↗

Toward Precision Medicine with Human Pluripotent Stem Cells for DiabetesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.